DESIGNATION PROCESS. 16 ARTICLE V RESTRICTIONS ON USE OF COLLABORATION RECEPTORS BY ARENA 17 ARTICLE VI RECEPTOR POOL 20 6.1 RECEPTOR POOL................................................................ 20 ARTICLE VII RESEARCH AND DEVELOPMENT PLAN 21 7.1 RESEARCH AND DEVELOPMENT PLAN................................................ 21 7.2 RESEARCH AND DEVELOPMENT PLAN TIME PERIOD.................................... 21 7.3 RESEARCH PLAN FTES........................................................... 22 7.4 RESEARCH AND DEVELOPMENT PLAN PRIORITIZED RECEPTORS.......................... 22 7.5 COLLABORATION................................................................ 23 ARTICLE VIII DISCOVERY MILESTONE PAYMENTS 24 ARTICLE IX CLINICAL DEVELOPMENT MILESTONE PAYMENTS 25 ARTICLE X ROYALTIES 26 10.3 ROYALTY TERM................................................................. 27 10.4 POST TERM RIGHTS............................................................. 28 10.5
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (Arena Pharmaceuticals Inc), Research Collaboration and License Agreement (Arena Pharmaceuticals Inc)